Access Resources
7411 - 7420 of 7616 Results
Title
Year
- Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?2009RESTRICTEDTitle: Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?Journal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 147End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-009-0620-2Best OA location URL: https://europepmc.org/articles/pmc2928051?pdf=renderCitation Count: 44
- Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease2009RESTRICTEDTitle: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s DiseaseJournal Name: Neurotoxicity ResearchPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12640-009-9140-zBest OA location URL: https://europepmc.org/articles/pmc3603276?pdf=renderCitation Count: 202
-
RESTRICTEDTitle: Glutamate Receptors as Therapeutic Targets for Parkinsons DiseaseJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 8Issue #: 6Start Page: 475End Page: 491Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152709789824606Best OA location URL: https://europepmc.org/articles/pmc3005251?pdf=renderCitation Count: 223
- Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum2009RESTRICTEDTitle: Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulumJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 390Issue #: 3Start Page: 758End Page: 762Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2009.10.045Best OA location URL: https://europepmc.org/articles/pmc3014991?pdf=renderCitation Count: 53
- Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways2009RESTRICTEDTitle: Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysJournal Name: SynapsePublisher: WileyVol: 64Issue #: 3Start Page: 251End Page: 266Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/syn.20725Best OA location URL: https://europepmc.org/articles/pmc3821045?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://europepmc.org/articles/pmc2839805?pdf=renderCitation Count: 366
- Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons2009RESTRICTEDTitle: Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 111Issue #: 5Start Page: 1202End Page: 1212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.06404.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2009.06404.xCitation Count: 52
-
RESTRICTEDTitle: Microglial responses to dopamine in a cell culture model of Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 30Issue #: 11Start Page: 1805End Page: 1817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2008.01.001Best OA location URL: https://europepmc.org/articles/pmc2762863?pdf=renderCitation Count: 94
-
RESTRICTEDTitle: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s diseaseJournal Name: BiomarkersPublisher: Informa UK LimitedVol: 14Issue #: 7Start Page: 493End Page: 501Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3109/13547500903108423Best OA location URL: https://europepmc.org/articles/pmc2824250?pdf=renderCitation Count: 103
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: function in cells and neurodegenerationJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6436End Page: 6444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07342.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-4658.2009.07342.xCitation Count: 32